News

News Release 31-Mar-2023 Status epilepticus: New inflammatory markers to improve patient care Peer-Reviewed Publication Institut du Cerveau (Paris Brain Institute) ...
It is FDA-approved for adult and pediatric use in the U.S. to treat generalized tonic-clonic status epilepticus, prevent and treat seizures occurring during neurosurgery, and for substitution ...
Most seizures last less than 2 minutes. Status epilepticus seizures keep going, or they come nonstop, one after another. Learn how to recognize this medical emergency.
Non-convulsive status epilepticus (NCSE) has historically been difficult to diagnose due to the lack of evidence-based criteria or consensus on electrographic patterns of status epilepticus (SE ...
Of 9,176 prehospital encounters for status epilepticus across 743 EMS agencies, 83.6% were treated with midazolam, 13.8% with lorazepam, and 2.7% with diazepam.
Silbergleit noted that about 60% to 70% of patients in status epilepticus respond to benzodiazepines, "but that means 30% to 40% do not." He explained that there has been a gap in knowing how to ...
Therapeutic cooling of patients with status epilepticus did not provide neuroprotection in addition to standard of care in a new trial, but it may provide an anticonvulsive effect.
Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study. Epilepsy Research, 2017; 133: 13 DOI: 10.1016/j.eplepsyres.2017.03.009 ...
Correspondence Treatment of Out-of-Hospital Status Epilepticus Published December 27, 2001 N Engl J Med 2001;345: 1913 - 1914 DOI: 10.1056/NEJM200112273452611 ...